Construction of a self-management scheme for osteoporosis related to endocrine therapy in patients with early-stage breast cancer
10.3760/cma.j.cn211501-20240927-02675
- VernacularTitle:早期乳腺癌患者内分泌治疗相关骨质疏松自我管理方案的构建
- Author:
Yan MA
1
;
Zhenqi LU
;
Jiajia QIU
;
Weiwu LU
;
Yun LI
;
Lichen TANG
;
Ping LI
Author Information
1. 复旦大学附属肿瘤医院护理部，上海 200032
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Osteoporosis;
Endocrine therapy;
Self-management;
Construction of scheme
- From:
Chinese Journal of Practical Nursing
2025;41(28):2220-2229
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To construct a self-management scheme for osteoporosis related to endocrine therapy in patients with early-stage breast cancer, so as to provide a reference for clinical nursing intervention.Methods:In the chronic disease self-management domain theory as the instruction, using literature research, the semi-structured interview to build the first draft of the plan, through the expert meeting law to plan to revise the first draft, and form a self-management scheme for osteoporosis related to endocrine therapy in patients with early-stage breast cancer.Results:A total of 10 experts were included, aged 37-47 (42.70 ± 3.43) years. The recovery rate of the expert questionnaire was 10/10, the expert authority coefficient was 0.93, and the coefficient of variation of each item ranged from 0.06 to 0.19. The final formed self-management scheme for osteoporosis related to endocrine therapy in patients with early-stage breast cancer includes three intervention modules: self-prevention, self-monitoring, and self-coping. It encompasses six intervention themes: enhancing knowledge reserves, non-pharmacological prevention, pharmacological prevention, risk assessment and self-reporting of symptoms, non-pharmacological intervention, and pharmacological intervention.Conclusions:The construction of the self-management scheme for osteoporosis related to endocrine therapy in patients with early-stage breast cancer is of great significance. The content of the scheme is scientific, reliable and targeted, which can provide guidance for the self-management of osteoporosis in patients with early breast cancer during endocrine therapy.
